These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22713708)

  • 1. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
    Philip A; Sivaprakasam P; Sagar TG; Ganesan P
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
    Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
    [No Abstract]   [Full Text] [Related]  

  • 3. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
    Skiles JL; Imel EA; Christenson JC; Bell JE; Hulbert ML
    J Clin Oncol; 2011 Nov; 29(32):e779-82. PubMed ID: 21969513
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    Manzoor NF; Azim S; Fadoo Z
    J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of aspergillosis.
    Karthaus M
    Clin Infect Dis; 2008 Aug; 47(3):427; author reply 427-8. PubMed ID: 18605908
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease.
    Gomez-Moyano E; Vera-Casaño A; Moreno-Perez D; Sanz-Trelles A; Crespo-Erchiga V
    Pediatr Dermatol; 2010; 27(1):105-6. PubMed ID: 20199430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole induced bradycardia.
    Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
    Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole-associated myositis.
    Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
    J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical images: voriconazole-induced periostitis deformans.
    Becce F; Malghem J; Lecouvet FE; Vande Berg BC; Omoumi P
    Arthritis Rheum; 2012 Oct; 64(10):3490. PubMed ID: 22777747
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
    Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
    Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole-associated severe hyponatremia.
    Kim KH; Lee S; Lee S; Yun NR; Kim NJ; Yu KS; Jang IJ; Park WB; Oh MD
    Med Mycol; 2012 Jan; 50(1):103-5. PubMed ID: 21671829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of voriconazole.
    Potoski BA; Brown J
    Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of pseudomembranous colitis after voriconazole therapy.
    Kwon JC; Kang MK; Kim SH; Choi SM; Kim HJ; Min WS; Lee DG
    Yonsei Med J; 2011 Sep; 52(5):863-5. PubMed ID: 21786455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary invasive oral aspergillosis: an updated literature review.
    Fuqua TH; Sittitavornwong S; Knoll M; Said-Al-Naief N
    J Oral Maxillofac Surg; 2010 Oct; 68(10):2557-63. PubMed ID: 20417591
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole-associated phototoxicity.
    Riahi RR; Cohen PR
    Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.